BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21079551)

  • 1. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection.
    Liacini A; Seamone ME; Muruve DA; Tibbles LA
    Transplantation; 2010 Dec; 90(12):1450-7. PubMed ID: 21079551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide use in renal transplantation.
    Leca N
    Curr Opin Organ Transplant; 2009 Aug; 14(4):370-4. PubMed ID: 19512928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients.
    Duclos AJ; Krishnamurthi V; Lard M; Poggio E; Kleeman M; Winans C; Fatica R; Nurko S
    Transplant Proc; 2006 Dec; 38(10):3666-72. PubMed ID: 17175362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BK viral disease in renal transplantation.
    Cannon RM; Ouseph R; Jones CM; Hughes MG; Eng M; Marvin MR
    Curr Opin Organ Transplant; 2011 Dec; 16(6):576-9. PubMed ID: 22027587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.
    Teschner S; Gerke P; Geyer M; Wilpert J; Krumme B; Benzing T; Walz G
    Transplant Proc; 2009; 41(6):2533-8. PubMed ID: 19715969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BK virus nephropathy and kidney transplantation.
    Bohl DL; Brennan DC
    Clin J Am Soc Nephrol; 2007 Jul; 2 Suppl 1():S36-46. PubMed ID: 17699509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyomavirus in renal transplantation: a hot problem.
    Bonvoisin C; Weekers L; Xhignesse P; Grosch S; Milicevic M; Krzesinski JM
    Transplantation; 2008 Apr; 85(7 Suppl):S42-8. PubMed ID: 18401263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients.
    Araya CE; Garin EH; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2010 Feb; 14(1):145-50. PubMed ID: 19344337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.
    Nickeleit V; Klimkait T; Binet IF; Dalquen P; Del Zenero V; Thiel G; Mihatsch MJ; Hirsch HH
    N Engl J Med; 2000 May; 342(18):1309-15. PubMed ID: 10793163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-center experience with BK virus nephropathy.
    Ott U; Steiner T; Busch M; Gerth J; Wolf G
    Clin Nephrol; 2008 Apr; 69(4):244-50. PubMed ID: 18397698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapy.
    Cuellar-Rodriguez J; Stephany B; Poggio E; Mossad SB; Goldfarb D; Lard M; Askar M; Fatica R; Srinivas T; Braun W; Shoskes D; Flechner S; Schmitt SK; Shrestha R; Avery RK
    Clin Transplant; 2013; 27(3):E230-6. PubMed ID: 23551281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy.
    Hirsch HH; Mohaupt M; Klimkait T
    J Infect Dis; 2001 Dec; 184(11):1494-5; author reply 1495-6. PubMed ID: 11709797
    [No Abstract]   [Full Text] [Related]  

  • 16. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.
    Faguer S; Hirsch HH; Kamar N; Guilbeau-Frugier C; Ribes D; Guitard J; Esposito L; Cointault O; Modesto A; Lavit M; Mengelle C; Rostaing L
    Transpl Int; 2007 Nov; 20(11):962-9. PubMed ID: 17666021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy.
    Wu JK; Harris MT
    Ann Pharmacother; 2008 Nov; 42(11):1679-85. PubMed ID: 18957628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
    Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
    Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
    Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
    Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria.
    Sadeghi M; Daniel V; Schnitzler P; Lahdou I; Naujokat C; Zeier M; Opelz G
    Transplantation; 2009 Nov; 88(9):1109-16. PubMed ID: 19898207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.